Kazia Therapeutics (KZIA) EPS (Basic) (2009 - 2011)

Kazia Therapeutics (KZIA) posted EPS (Basic) of -$0.01 for Q4 2011, up 82.41% on a QoQ basis from -$0.04 in Q4 2010, and up 82.41% year-over-year from -$0.0 in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of EPS (Basic) data on file, last reported at -$0.01 in Q4 2011.

  • In Q4 2011, EPS (Basic) rose 82.41% year-over-year to -$0.01; the TTM figure through Dec 2016 stood at -$0.01 (changed N/A YoY), while the FY2025 annual figure was -$0.02, up 63.84% from the prior year.
  • EPS (Basic) rose to -$0.01 in Q4 2011, from -$0.04 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.01 in Q4 2011 and bottomed at -$0.05 in Q4 2009.
  • A 3-year average of -$0.03 and a median of -$0.03 in 2009 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2010 — EPS (Basic) climbed 18.56% — and 2011, when it soared 82.41%.
  • Year by year, EPS (Basic) stood at -$0.05 in 2009, then grew by 18.56% to -$0.04 in 2010, then soared by 82.41% to -$0.01 in 2011.
  • The last three EPS (Basic) figures came in at -$0.01 (Q4 2011), -$0.04 (Q4 2010), and -$0.05 (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -0.01
Dec 31, 2010 -0.04
Dec 31, 2009 -0.05
Jun 30, 2009 -0.02